Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C
Publication Type:
Journal Article
Authors:
Arase, Y.;
Suzuki, F.;
Suzuki, Y.;
Akuta, N.;
Kobayashi, M.;
Kawamura, Y.;
Yatsuji, H.;
Sezaki, H.;
Hosaka, T.;
Hirakawa, M.;
Ikeda, K.;
Kumada, H.Source:
Hepatology, Volume 49, Issue 3, p.739-744 (2009)
Keywords:
Adult,
analysis,
Antiviral Agents,
blood,
Cohort Studies,
Diabetes Mellitus,Type 2,
drug effects,
drug therapy,
Drug Therapy,Combination,
epidemiology,
Fasting,
Female,
Follow-Up Studies,
genetics,
HCV,
Hepacivirus,
hepatitis,
Hepatitis C,
hepatitis C virus,
Hepatitis C,Chronic,
Humans,
Incidence,
Infection,
interferon,
Interferon Alfa-2b,
Interferon-alpha,
Japan,
Kaplan-Meier Estimate,
Male,
Middle Aged,
monotherapy,
Observation,
Outcome Assessment (Health Care),
pathology,
Patients,
peginterferon,
peginterferon alfa-2b,
pharmacology,
physiology,
Polyethylene Glycols,
prevention & control,
Proportional Hazards Models,
Proteins,
Recombinant Proteins,
Research,
Research Support,
Retrospective Studies,
Ribavirin,
Risk,
Risk Factors,
Rna,
Rna,Viral,
therapeutic use,
therapy
